Good read, thanks. SPL continues to tick all the right boxes. I think the fact that it's Australian and listed on the ASX keeps it under the radar, but it's only a matter of time before this stock is worth $10+ a share. Maybe this time next year? Personally I think they we will bought out before then, once the data starts to come in for phase 2 DEP DOC, and the FDA approval comes through for VivaGel. Hopefully it will spark a bidding war.
Very interesting article, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |